FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and medicine, namely transfusiology, and is applicable for ozonation of Perftoran and other foam solutions and emulsions. A method is implemented as follows. Perftoran is bubbled with an ozone-oxygen mixture for 15-20 minutes at 0.5 l/min and at the preset ozone concentration (required, recommended concentration) in any medical ozon plant. It requires making available an original vial (bottle) with Perftoran, a sterile empty vial (bottle) 200, 250 or 400 ml sealed with a rubber cap with an aluminium capsule. The vial with Perftoran shall be coupled with the empty sterile vial through a PVC tube by sticking in needles connected to the tube ends in each vial. In this case, a tube for mixed gas disposal into a destructor does not extend from the vial with Perftoran, but from the second coupled empty vial that prevents Perftoran from the ingress into the desctructor.
EFFECT: method is technically easy-to-implement and allows using ozonised Perftoran both externally in the form of applications or skin wound irrigations, and for introduction in serous cavities for sanation, as well as intravenously.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INTRAPORTAL OZONE THERAPY IN PATIENTS WITH WIDESPREAD PERITONITIS | 2015 |
|
RU2594512C1 |
PHYSIOLOGICAL SOLUTION OZONATION METHOD | 2023 |
|
RU2814268C1 |
METHOD FOR OZONIZING OF PHYSIOLOGICAL SALT SOLUTION | 2004 |
|
RU2289413C2 |
METHOD FOR TREATING ACUTE PURULENT INFLAMMATION IN SEROUS CAVITY | 2003 |
|
RU2249451C2 |
METHOD FOR PREVENTION OF POSTOPERATIVE ENTEROPARESIS | 2009 |
|
RU2445130C2 |
METHOD OF TREATING STAPHYLOCOCCUS AUREUS CULTURE WITH OXYGEN-CONTAINING GAS FROM PORTABLE OZONISER | 2018 |
|
RU2709720C1 |
DEVICE FOR INTRAVENOUS INFUSIONS IN OZONE THERAPY | 2021 |
|
RU2758124C1 |
METHOD OF PREVENTING POSTOPERATIVE COMMISSURAL PROCESS IN ABDOMINAL CAVITY | 2009 |
|
RU2432944C2 |
METHOD FOR TREATING CRITICAL ISCHEMIA OF LOWER EXTREMITIES | 2005 |
|
RU2289396C1 |
CONCENTRATED SOLUTION OF STABILISED OZONE FOR TREATMENT OF INFLAMMATORY PROCESSES | 2006 |
|
RU2324468C2 |
Authors
Dates
2012-03-20—Published
2009-06-03—Filed